Cargando…
CFTR targeted therapies: recent advances in cystic fibrosis and possibilities in other diseases of the airways
Cystic fibrosis transmembrane conductance regulator (CFTR) is an ion transporter that regulates mucus hydration, viscosity and acidity of the airway epithelial surface. Genetic defects in CFTR impair regulation of mucus homeostasis, causing severe defects of mucociliary clearance as seen in cystic f...
Autores principales: | Patel, Sheylan D., Bono, Taylor R., Rowe, Steven M., Solomon, George M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131734/ https://www.ncbi.nlm.nih.gov/pubmed/32554756 http://dx.doi.org/10.1183/16000617.0068-2019 |
Ejemplares similares
-
The Effect of CFTR Modulators on Airway Infection in Cystic Fibrosis
por: Harvey, Caitlyn, et al.
Publicado: (2022) -
Changes in the Cystic Fibrosis Airway Microbiome in Response to CFTR Modulator Therapy
por: Yi, Buqing, et al.
Publicado: (2021) -
CFTR Modulator Therapies: Potential Impact on Airway Infections in Cystic Fibrosis
por: Saluzzo, Francesca, et al.
Publicado: (2022) -
Recent Progress in CFTR Interactome Mapping and Its Importance for Cystic Fibrosis
por: Lim, Sang Hyun, et al.
Publicado: (2018) -
Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis
por: Sermet-Gaudelus, Isabelle, et al.
Publicado: (2018)